A correlation between obesity and income has only developed in the past 30 years

December 11, 2018

It is well known that poorer Americans are more likely to be obese or suffer from diabetes; there is a strong negative correlation between household income and both obesity and diabetes. This negative correlation, however, has only developed in the past 30 years, according to researchers in Tennessee and London. Since 1990, the rise of obesity and diabetes was fastest among the poorest U.S. regions, says Alexander Bentley of the University of Tennessee in the US. The timing also fits with the generations exposed to high fructose corn syrup in foodstuffs and drinks, says Bentley, who is the lead author of a study in the journal Palgrave Communications, which is published by Springer Nature.

Experts describe the unprecedented rise in obesity in recent history as the most rapid change ever seen in human physiology. Only a century ago, obesity was a phenomenon almost unknown to citizens of the US and other developed countries.

In this study, Bentley and his colleagues analyzed data made available by the Centre of Disease Control and Prevention about obesity levels, leisure activities, income rates and incidences of diabetes. In most cases, this data was compiled for around 3000 US counties. The researchers also drew on data collected by the Food Access Research Atlas project. These documented a person's access to vehicles and proximity to supermarkets and large grocery stores where they could buy affordable and nutritious food.

The analysis shows that in 1990, when population-scale obesity rates in the US were about a third of what they are today, there was no link between income and obesity or diabetes. By 2015, there was a strong likelihood that obesity or diabetes would be typical in lower income households. In states like Alabama, Mississippi and West Virginia, where the average household income was below 45,000 US dollars a year, 35 per cent of people were obese. In more affluent states such as Colorado, Massachusetts or California, where households earned on average 65 000 US dollars a year, one in four citizens was obese.

"The data point to a developing trend that was not present in 1990. This negative correlation has evolved steadily over recent decades," explains Bentley. "By 2015 the situation was such that members of lower income households had a much greater chance of suffering from obesity and diabetes."

Bentley and his colleagues speculate that the oversupply and ready access to foodstuffs containing high fructose corn syrup may be driving obesity levels. In the past, people's diets contained very little sugar and no refined carbohydrates. Overall sugar consumption in the American diet has risen gradually in the 20th century, from 12 per cent of US food energy in 1909 to 19 per cent by the year 2000.

"The timing is suggestive, with the generations of young Americans consuming high fructose corn syrup in foodstuffs predicting a similar increase in obesity as they became adults," Bentley notes.

High fructose corn syrup has been used in US foodstuffs since 1970. By the year 2000, each person in the US consumed on average around 27 kilograms (60 pounds) of it per year, which is about half of their annual total sugar intake. Corn syrup is the main sweetener in soft drinks. In 2016 the average US household spent 7 per cent and low income households spent 9 per of their income on soft drinks.
-end-
Reference: Bentley. R.A. et al (2018). Recent origin and evolution of obesity-income correlation across the United States, Palgrave Communications DOI: 10.1057/s41599-018-0201-x

Springer

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.